Singapore markets closed

Entourage Health Corp. (ETRGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.01050.0000 (0.00%)
As of 02:43PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.0105
Open0.0148
BidN/A x N/A
AskN/A x N/A
Day's range0.0105 - 0.0105
52-week range0.0021 - 0.0210
Volume44,495
Avg. volume20,495
Market cap3.25M
Beta (5Y monthly)1.21
PE ratio (TTM)N/A
EPS (TTM)-0.2700
Earnings date27 May 2024 - 31 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Entourage Health Full Year 2023 Earnings: CA$0.15 loss per share (vs CA$0.40 loss in FY 2022)

    Entourage Health ( CVE:ENTG ) Full Year 2023 Results Key Financial Results Revenue: CA$40.7m (flat on FY 2022). Net...

  • GlobeNewswire

    Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

    Strategic Cost Management Signals Stronger Financial Health and Future StabilityGross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A declined 14% compared to the previous year.Color Cannabis secures a #6 spot in the national pre-roll market. TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage"

  • GlobeNewswire

    Entourage Health to Report Fiscal Year 2023 Financial Results

    Company Financials for Full-Year 2023 will be filed after market close on April 29, 2024TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis products, announced today that it will file its financial statements and management's discussion and analysis for the fourth quarter and fiscal year ended December 31, 2023, after market close on April 29, 2024.